6.
Kato M, Putta S, Wang M, Yuan H, Lanting L, Nair I
. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol. 2009; 11(7):881-9.
PMC: 2744130.
DOI: 10.1038/ncb1897.
View
7.
Das F, Ghosh-Choudhury N, Venkatesan B, Kasinath B, Ghosh Choudhury G
. PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression. Am J Physiol Renal Physiol. 2017; 313(2):F291-F307.
PMC: 5582895.
DOI: 10.1152/ajprenal.00666.2016.
View
8.
Houde V, Brule S, Festuccia W, Blanchard P, Bellmann K, Deshaies Y
. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. Diabetes. 2010; 59(6):1338-48.
PMC: 2874694.
DOI: 10.2337/db09-1324.
View
9.
Lee H, Lee D, Mariappan M, Feliers D, Ghosh-Choudhury G, Abboud H
. Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. J Biol Chem. 2017; 292(14):5665-5675.
PMC: 5392562.
DOI: 10.1074/jbc.M116.766758.
View
10.
Laplante M, Sabatini D
. mTOR signaling in growth control and disease. Cell. 2012; 149(2):274-93.
PMC: 3331679.
DOI: 10.1016/j.cell.2012.03.017.
View
11.
Bonifati V, Rizzu P, van Baren M, Schaap O, Breedveld G, Krieger E
. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2002; 299(5604):256-9.
DOI: 10.1126/science.1077209.
View
12.
Tamura M, Gu J, Danen E, Takino T, Miyamoto S, Yamada K
. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 1999; 274(29):20693-703.
DOI: 10.1074/jbc.274.29.20693.
View
13.
Mariappan M, Prasad S, DSilva K, Cedillo E, Sataranatarajan K, Barnes J
. Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury. J Biol Chem. 2014; 289(51):35363-75.
PMC: 4271222.
DOI: 10.1074/jbc.M114.587840.
View
14.
Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A
. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun. 2005; 340(1):296-301.
DOI: 10.1016/j.bbrc.2005.12.012.
View
15.
Franz S, Regeniter A, Hopfer H, Mihatsch M, Dickenmann M
. Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial. Am J Kidney Dis. 2009; 55(2):335-43.
DOI: 10.1053/j.ajkd.2009.09.004.
View
16.
Inoki K
. Role of TSC-mTOR pathway in diabetic nephropathy. Diabetes Res Clin Pract. 2008; 82 Suppl 1:S59-62.
DOI: 10.1016/j.diabres.2008.09.028.
View
17.
Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Ariga H
. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997; 231(2):509-13.
DOI: 10.1006/bbrc.1997.6132.
View
18.
Wilson M
. The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal. 2010; 15(1):111-22.
PMC: 3110098.
DOI: 10.1089/ars.2010.3481.
View
19.
Jha J, Banal C, Chow B, Cooper M, Jandeleit-Dahm K
. Diabetes and Kidney Disease: Role of Oxidative Stress. Antioxid Redox Signal. 2016; 25(12):657-684.
PMC: 5069735.
DOI: 10.1089/ars.2016.6664.
View
20.
Kim R, Smith P, Aleyasin H, Hayley S, Mount M, Pownall S
. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A. 2005; 102(14):5215-20.
PMC: 555037.
DOI: 10.1073/pnas.0501282102.
View